Literature DB >> 18707712

The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.

Beverley A Shannon1, Ronald J Cohen, Hildemarie de Bruto, Robert J Davies.   

Abstract

PURPOSE: We determined the safety and accuracy of preoperative needle core biopsy for diagnosing benign lesions among small incidental asymptomatic renal masses.
MATERIALS AND METHODS: Between February 2000 and December 2007 we received a total of 235 preoperative core biopsies from 222 less than 5 cm incidental renal masses. Biopsy results were correlated with surgical specimen final pathology findings or with patient followup if surgery was avoided.
RESULTS: Of the 235 biopsies 184 (78%) were diagnostic, whereas 51 (22%) were nondiagnostic due to insufficient material or contents of only normal, inflammatory, fibrotic or necrotic tissue, or blood clot. Diagnostic biopsies revealed 138 malignant (75%) and 46 benign (25%) lesions. Of these patients 108 (59%) underwent renal surgery, which showed a 100% biopsy accuracy rate for distinguishing malignant from benign lesions and a 98% rate for determining histological tumor type. Followup with radiological imaging was performed for 59 lesions in patients with nondiagnostic biopsies or benign masses and for 16 low grade malignant tumors in elderly patients. Lesions remained stable in 61 cases, showed minor size changes in 9 and resolved in 5. No patient has shown symptoms or required renal surgery to date. Significant biopsy related complications were noted in only 2 patients (0.9%).
CONCLUSIONS: We found that needle core biopsy was a safe and accurate technique for distinguishing between malignant and benign tumors in small asymptomatic incidentally detected renal masses. Biopsy of small tumors is associated with a relatively high rate of technical biopsy failure, although this may be addressed by adopting improved biopsy techniques, as discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18707712     DOI: 10.1016/j.juro.2008.06.030

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  47 in total

1.  CT fluoroscopy-guided renal tumour cutting needle biopsy: retrospective evaluation of diagnostic yield, safety, and risk factors for diagnostic failure.

Authors:  Toshihiro Iguchi; Takao Hiraki; Yusuke Matsui; Hiroyasu Fujiwara; Jun Sakurai; Yoshihisa Masaoka; Hideo Gobara; Susumu Kanazawa
Journal:  Eur Radiol       Date:  2017-08-02       Impact factor: 5.315

Review 2.  Active surveillance for low-risk prostate cancer: an update.

Authors:  Nathan Lawrentschuk; Laurence Klotz
Journal:  Nat Rev Urol       Date:  2011-04-26       Impact factor: 14.432

3.  Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses.

Authors:  Aliaksei Chyhrai; Jimsgene Sanjmyatav; Mieczyslaw Gajda; Olaf Reichelt; Heiko Wunderlich; Thomas Steiner; Enis Tanović; Kerstin Junker
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

4.  The role of percutaneous renal biopsy in the management of small renal masses.

Authors:  Rou Wang; Amy Y Li; David P Wood
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 5.  The role of renal biopsy in small renal masses.

Authors:  Rodolfo Burruni; Benoit Lhermitte; Yannick Cerantola; Thomas Tawadros; Jean-Yves Meuwly; Dominik Berthold; Patrice Jichlinski; Massimo Valerio
Journal:  Can Urol Assoc J       Date:  2016-01-14       Impact factor: 1.862

6.  Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.

Authors:  Serge Ginzburg; Robert Uzzo; Tahseen Al-Saleem; Essel Dulaimi; John Walton; Anthony Corcoran; Elizabeth Plimack; Reza Mehrazin; Jeffrey Tomaszewski; Rosalia Viterbo; David Y T Chen; Richard Greenberg; Marc Smaldone; Alexander Kutikov
Journal:  J Urol       Date:  2013-07-27       Impact factor: 7.450

Review 7.  Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature.

Authors:  Hiten D Patel; Michael H Johnson; Phillip M Pierorazio; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-02-18       Impact factor: 7.450

8.  Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings.

Authors:  Joel Prince; Eric Bultman; Louis Hinshaw; Anna Drewry; Michael Blute; Sara Best; Fred T Lee; Timothy Ziemlewicz; Meghan Lubner; Fangfang Shi; Stephen Y Nakada; E Jason Abel
Journal:  J Urol       Date:  2014-12-11       Impact factor: 7.450

9.  Microarray gene expression profiling using core biopsies of renal neoplasia.

Authors:  Craig G Rogers; Jonathon A Ditlev; Min-Han Tan; Jun Sugimura; Chao-Nan Qian; Jeff Cooper; Brian Lane; Michael A Jewett; Richard J Kahnoski; Eric J Kort; Bin T Teh
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.